Name of opportunity: 👀
Merck & Co. Inc
Rising in price 📈
Merck & Co has seen a recent rise in price, with the stock’s value going up by 1.13% in the past day, and 0.22% in the past week. Merck & Co is an income stock, which means shareholders might receive a portion of its profits through dividend payments.
Merck & Co offers a 2.57% dividend yield, paying $3.04 per share in the last 12 months. If you invested $1000, you might receive $25.70 yearly in dividends.
Analysts are currently calling Merck & Co a ‘buy’, meaning now might be a good time to invest.
How hot is this investment opportunity? 🔥🔥🔥
Analysts predict the price of Merck & Co. Inc. might increase from $99.48 to $136.02 in the next 12 months. If you invested $1000, you might profit $367.26.
One reason why Merck & Co has seen a price increase might be because the company recently won UK approval for a drug to treat lung disease that was approved by the US and the European Union in 2024.
Merck & Co gained access to the drug sotatercept when they acquired Acceleron Pharma in 2021 in an $11 billion deal. Sotatercept is sold under the brand name Winrevair, and is used to treat adults with pulmonary arterial hypertension.
Merck & Co has also recently made a deal to gain the exclusive global license to a new weight loss pill that Chinese company Hansoh Pharma have been working on. Weight loss pills are a hot topic right now as weight loss injections have soared in popularity - this dosage method would offer greater convenience.
Global healthcare company 🧑⚕️
Merck & Co. Inc. is an American multinational pharmaceutical company that offers health solutions through biological therapies, vaccines, and prescription medicines. The company is headquartered in Rahway, New Jersey, United States.
Which neme?: 🔍
‘Dividend Deadlines’, ‘Pharma’, ‘Low Volatility Stocks’.
Download Nemo Money to check out Merck & Co. Inc. New users can grab our registration bonus up to a maximum of $50. Top up your account and get 50% extra from us. Terms and conditions apply
